Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G Feb 14, 2017 SC 13G
8-K Feb 14, 2017 FORM 8-K
SC 13G/A Feb 14, 2017 PRIMARY DOCUMENT
SC 13G/A Feb 14, 2017
SC 13G/A Feb 14, 2017
SC 13G Feb 1, 2017 SCHEDULE 13G
8-K Jan 9, 2017 FORM 8-K
SC 13G/A Jan 4, 2017
8-K Jan 3, 2017 8-K
8-K Dec 27, 2016 FORM 8-K
SC 13G Dec 23, 2016 PROTALIX BIOTHERAPEUTICS, INC.
8-K Dec 14, 2016 FORM 8-K
8-K Dec 7, 2016 8-K
4 Dec 6, 2016 PRIMARY DOCUMENT
8-K Dec 2, 2016 8-K
8-K Nov 30, 2016 FORM 8-K
8-K Nov 22, 2016 FORM 8-K
10-Q Nov 9, 2016 FORM 10-Q
8-K Nov 9, 2016 FORM 8-K
8-K Oct 25, 2016 FORM 8-K
4 Sep 16, 2016 OWNERSHIP DOCUMENT
8-K Aug 10, 2016 FORM 8-K
10-Q Aug 8, 2016 FORM 10-Q
8-K Aug 8, 2016 FORM 8-K
8-K Jul 7, 2016 8-K
← Newer Page 17 of 38 · 935 filings Older →